Detalhe da pesquisa
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med
; 21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502656
2.
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
N Engl J Med
; 384(12): 1089-1100, 2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761206
3.
Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline.
BMC Med Res Methodol
; 23(1): 147, 2023 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355583
4.
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
N Engl J Med
; 369(22): 2083-92, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099601
5.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090638
6.
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
Open Forum Infect Dis
; 2(3): ofv082, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26199949